ClinicalTrials.Veeva

Menu

The Teen Marijuana Check-Up (TMCU3)

University of Washington logo

University of Washington

Status and phase

Completed
Phase 2

Conditions

Cannabis Dependence
Cannabis Abuse

Treatments

Behavioral: Motivational enhancement therapy
Behavioral: Marijuana education

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00350285
01-8666-G-05
R01DA014296 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This behavioral research is an efficacy trial evaluating an intervention called "The Teen Marijuana Check-Up" with non-treatment seeking adolescent marijuana users.

Full description

Three hundred adolescents who smoke marijuana (ages 14-19), recruited in four Seattle-area high schools, will be enrolled in the trial. Participants will be recruited either through in-class presentations focusing on marijuana or via referrals from school staff. They will first be assessed regarding use of marijuana, alcohol, and other drugs, as well as pertinent attitudes and goals. Participants will then be randomly assigned to one of three conditions.

  • The experimental intervention is a two-session motivational enhancement treatment. A personalized feedback report, containing information from the participant's assessment as well as normative comparison data, is reviewed, with the Health Educator employing motivational interviewing strategies intended to enhance motivation for reduction or cessation of marijuana use. Specific goals for change and behavior change strategies are discussed with participants who wish support to change their marijuana use.
  • The comparison condition involves two educational sessions focusing on the health and behavioral effects of marijuana.
  • The third condition (delayed treatment control) involves a minimal baseline assessment followed three months later by a reassessment interview. Those assigned to this condition will then be given their choice of either active treatment.

Following completion of their two intervention sessions, participants in the two active treatments will be offered an additional four sessions of cognitive-behavioral skills training in which the focus is strategies in quitting marijuana. All participants will be reassessed at 3 and 12 months following their initial assessment interviews.

Enrollment

310 patients

Sex

All

Ages

14 to 19 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: Individuals who contact the project will be screened according to the following inclusion criteria:

  • age (14-19 years old),
  • grade level (freshmen through seniors) and
  • marijuana use (smoked 9 or more days in past 30).

Exclusion Criteria: Individuals will be excluded if:

  • they are not fluent in English,
  • they have a thought disorder that precludes full participation,
  • they refuse to accept randomization to condition.

In addition to the inclusion and exclusion criteria, participants who appear to be in psychological or physical distress will be assessed further and referred to other services as appropriate. The need for other services will not necessarily preempt participation in the TMCU unless the individual is incapable or unwilling to complete the protocol. As was the case in our Stage 1b trial, all ineligible applicants will be offered a single feedback session, and the Strategies That Work booklet will be offered to those who indicate any interest in reducing or quitting marijuana use.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

310 participants in 3 patient groups

1
Experimental group
Description:
Motivational enhancement therapy
Treatment:
Behavioral: Motivational enhancement therapy
2
Active Comparator group
Description:
Marijuana education
Treatment:
Behavioral: Marijuana education
3
No Intervention group
Description:
Delayed treatment control condition

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems